BIOMAT Database Logo BIOMAT Database Logo

[Hemorheologic, metabolic and blood coagulation changes in diabetics in treatment with sulfanyl ureas]. 1988

A Cortinovis, and A Crippa, and V Sciacca, and V Caravaggio, and M Crippa
Università di Pavia, Semeiotica Medica, IRCCS, Policlinico San Matteo, Dipartimento di Medicina Interna e Terapia Medica.

A study was carried out to see if chronic treatment with a sulphanylurea with hypoglycaemic action, with also haemoactive action in terms of anti-platelet aggregation, profibrinolytic and antifibrinogenetic action also acted haemorheologically. For this purpose a group of patients treated with Gliclazide was compared with a group under treatment with Glibenclamide. A significant variation was noted in terms of an increase in erythrocyte filtrability and a diminution in erythrocyte aggregation with diminution in blood viscosity at low shear-rates. The absence of parallel modifications in quantitative corpuscular viscous factors, the early onset of the process, the real diminution in the sense of a reduction below the range of normality suggests that the effect is pharmacological and not mediated by metabolic compensation.

UI MeSH Term Description Entries
D001777 Blood Coagulation The process of the interaction of BLOOD COAGULATION FACTORS that results in an insoluble FIBRIN clot. Blood Clotting,Coagulation, Blood,Blood Clottings,Clotting, Blood
D001809 Blood Viscosity The internal resistance of the BLOOD to shear forces. The in vitro measure of whole blood viscosity is of limited clinical utility because it bears little relationship to the actual viscosity within the circulation, but an increase in the viscosity of circulating blood can contribute to morbidity in patients suffering from disorders such as SICKLE CELL ANEMIA and POLYCYTHEMIA. Blood Viscosities,Viscosities, Blood,Viscosity, Blood
D003924 Diabetes Mellitus, Type 2 A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY. Diabetes Mellitus, Adult-Onset,Diabetes Mellitus, Ketosis-Resistant,Diabetes Mellitus, Maturity-Onset,Diabetes Mellitus, Non-Insulin-Dependent,Diabetes Mellitus, Slow-Onset,Diabetes Mellitus, Stable,MODY,Maturity-Onset Diabetes Mellitus,NIDDM,Diabetes Mellitus, Non Insulin Dependent,Diabetes Mellitus, Noninsulin Dependent,Diabetes Mellitus, Noninsulin-Dependent,Diabetes Mellitus, Type II,Maturity-Onset Diabetes,Noninsulin-Dependent Diabetes Mellitus,Type 2 Diabetes,Type 2 Diabetes Mellitus,Adult-Onset Diabetes Mellitus,Diabetes Mellitus, Adult Onset,Diabetes Mellitus, Ketosis Resistant,Diabetes Mellitus, Maturity Onset,Diabetes Mellitus, Slow Onset,Diabetes, Maturity-Onset,Diabetes, Type 2,Ketosis-Resistant Diabetes Mellitus,Maturity Onset Diabetes,Maturity Onset Diabetes Mellitus,Non-Insulin-Dependent Diabetes Mellitus,Noninsulin Dependent Diabetes Mellitus,Slow-Onset Diabetes Mellitus,Stable Diabetes Mellitus
D004907 Erythrocyte Deformability Ability of ERYTHROCYTES to change shape as they pass through narrow spaces, such as the microvasculature. Erythrocyte Filterability,Deformability, Erythrocyte,Filterability, Erythrocyte
D005905 Glyburide An antidiabetic sulfonylurea derivative with actions like those of chlorpropamide Glibenclamide,Daonil,Diabeta,Euglucon 5,Euglucon N,Glybenclamide,HB-419,HB-420,Maninil,Micronase,Neogluconin,HB 419,HB 420,HB419,HB420
D005907 Gliclazide An oral sulfonylurea hypoglycemic agent which stimulates insulin secretion. Diabrezide,Diaglyk,Diaikron,Diamicron,Gen-Gliclazide,Gliklazid,Glyade,Glyclazide,Novo-Gliclazide,S-1702,S-852,Gen Gliclazide,Novo Gliclazide,S 1702,S 852,S1702,S852
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012212 Rheology The study of the deformation and flow of matter, usually liquids or fluids, and of the plastic flow of solids. The concept covers consistency, dilatancy, liquefaction, resistance to flow, shearing, thixotrophy, and VISCOSITY. Flowmetry,Velocimetry,Velocimetries
D013453 Sulfonylurea Compounds A class of compounds in which a sulfone functional group is attached to UREA. Compounds, Sulfonylurea

Related Publications

A Cortinovis, and A Crippa, and V Sciacca, and V Caravaggio, and M Crippa
[Metabolic changes in blood and cerebrospinal fluid induced by sulfanyl butyl urea].
July 1957, La Riforma medica,
A Cortinovis, and A Crippa, and V Sciacca, and V Caravaggio, and M Crippa
Blood coagulation in maturity--onset diabetics before and after treatment with glibenclamide.
February 1972, Journal of the Medical Association of Thailand = Chotmaihet thangphaet,
A Cortinovis, and A Crippa, and V Sciacca, and V Caravaggio, and M Crippa
[Combined insulin and sulfanyl-ureas in therapy of diabetes mellitus].
January 1957, Bollettino - Societa medico chirurgica Cremona,
A Cortinovis, and A Crippa, and V Sciacca, and V Caravaggio, and M Crippa
[Hemorheologic and blood coagulation studies in 94 patients with chronic obstructive peripheral arterial disease].
January 1985, La Ricerca in clinica e in laboratorio,
A Cortinovis, and A Crippa, and V Sciacca, and V Caravaggio, and M Crippa
[Hemorheologic and retinal microcirculatory aspects of diabetics undergoing treatment with human insulin using microinfusors].
January 1984, Minerva endocrinologica,
A Cortinovis, and A Crippa, and V Sciacca, and V Caravaggio, and M Crippa
[Changes in blood coagulation in treatment with hydroxyethyl starch].
January 1998, Anaesthesiologie und Reanimation,
A Cortinovis, and A Crippa, and V Sciacca, and V Caravaggio, and M Crippa
[Behavior of blood coagulation in metabolic and respiratory pH-changes].
June 1968, Monatsschrift fur Kinderheilkunde,
A Cortinovis, and A Crippa, and V Sciacca, and V Caravaggio, and M Crippa
Metabolic and blood coagulation changes during intravenous fat infusions.
May 1968, Annals of the Royal College of Surgeons of England,
A Cortinovis, and A Crippa, and V Sciacca, and V Caravaggio, and M Crippa
[Disorders of blood coagulation and microcirculation in diabetics].
January 1989, Problemy endokrinologii,
A Cortinovis, and A Crippa, and V Sciacca, and V Caravaggio, and M Crippa
[Clinical use of sulfonyl ureas in diabetics with tuberculosis].
January 1957, Giornale italiano della tubercolosi,
Copied contents to your clipboard!